Fingerprint
Dive into the research topics where Robert Greig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Are phenotypic baseline characteristics related to abolition of AHR after benralizumab and dupilumab?
Suter, P. (Lead / Corresponding author), Greig, R., Chan, R. & Lipworth, B. J., 10 Mar 2026, (E-pub ahead of print) In: Clinical and Experimental Allergy. 4 p.Research output: Contribution to journal › Letter › peer-review
Open AccessFile4 Downloads (Pure) -
Bucher indirect treatment comparison of phase 3 trials with dupilumab and tezepelumab in chronic rhinosinusitis with nasal polyps
Suter, P. (Lead / Corresponding author), Greig, R. & Lipworth, B. J., 22 Jan 2026, (E-pub ahead of print) In: Annals of Allergy, Asthma and Immunology.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Dupilumab and lymphoma risk among patients with asthma
Lipworth, B. (Lead / Corresponding author), Suter, P. & Greig, R., 19 Feb 2026, In: European Respiratory Journal. 67, 2, 2501380.Research output: Contribution to journal › Letter › peer-review
-
Impact of dupilumab on united airways disease
Suter, P., Greig, R. & Lipworth, B. J. (Lead / Corresponding author), Apr 2026, In: Annals of Allergy, Asthma and Immunology. 136, 4, p. 372-373 2 p.Research output: Contribution to journal › Editorial › peer-review
-
New Perspectives on Effects of Biologics on Mannitol Airway Hyperresponsiveness
Greig, R., Suter, P., Chan, R. & Lipworth, B. (Lead / Corresponding author), 22 Jan 2026, (E-pub ahead of print) In: Clinical and Experimental Allergy. p. 1-3 3 p.Research output: Contribution to journal › Editorial › peer-review
1 Link opens in a new tab Citation (Scopus)